• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
 
Generic Name:  trans sodium crocetinate
Trade Name:  n/a
Date Designated:  07/21/2011
Orphan Designation:  Treatment of glioblastoma in conjunction with radiotherapy
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Diffusion Pharmaceuticals, LLC
2020 Avon Court
Suite 4
Charlottesville, Virginia 22902

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-